A compound heterozygous mutation of the SPINK5 gene in a Taiwanese boy with Netherton syndrome

被引:0
作者
Chao, SC [1 ]
Tsai, YM [1 ]
Lee, JYY [1 ]
机构
[1] Natl Cheng Kung Univ Hosp, Dept Dermatol, Tainan 70428, Taiwan
关键词
ichthyosiform erythroderma; congenital; mutation; serine proteinase inhibitors; SPINK5; protein; human; Taiwan;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Netherton syndrome (NS) is a severe, autosomal, recessive ichthyosis. It is characterized by congenital ichthyosiform erythroderma (CIE), trichorrhexis invaginata (TI) - a distinctive hair-shaft anomaly, and atopic diathesis, Recently, pathogenic mutations were identified in serine protease inhibitor Kazal-type 5 (SPINK5), the gene that encodes lympho-epithelial Kazal-type-related inhibitor (LEKTI), a recently identified type of serine protease inhibitor involved in the regulation of skin barrier formation and immunity. Here we report the mutation analysis of a 7-year-old Taiwanese boy with NS manifesting CIE with pathognomic ichthyosis linearis circumflexa and TI. Direct DNA sequencing of SPINK5 demonstrated a compound heterozygous mutation in the proband, 2260A>T (K754X) in exon 24 and 2468delA in exon 26. The former is a novel mutation and was detected in the mother. The latter mutation was detected in the father and has been previously reported in several European families. Both mutations are expected to result in premature termination codons. Mutation analysis could provide a reliable prenatal diagnosis of this lethal ichthyosis.
引用
收藏
页码:418 / 423
页数:6
相关论文
共 19 条
[1]  
Allen A, 2001, ARCH DERMATOL, V137, P747
[2]   Prenatal diagnosis of a lethal form of Netherton syndrome by SPINK5 mutation analysis [J].
Bitoun, E ;
Bodemer, C ;
Amiel, J ;
de Prost, Y ;
Stoll, C ;
Calvas, P ;
Hovnanian, A .
PRENATAL DIAGNOSIS, 2002, 22 (02) :121-126
[3]   Netherton syndrome:: Disease expression and spectrum of SPINK5 mutations in 21 families [J].
Bitoun, E ;
Chavanas, S ;
Irvine, AD ;
Lonie, L ;
Bodemer, C ;
Paradisi, M ;
Hamel-Teillac, D ;
Ansai, S ;
Mitsuhashi, Y ;
Taïeb, A ;
de Prost, Y ;
Zambruno, G ;
Harper, JI ;
Hovnanian, A .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2002, 118 (02) :352-361
[4]   Localization of the Netherton syndrome gene to chromosome 5q32, by linkage analysis and homozygosity mapping [J].
Chavanas, S ;
Garner, C ;
Bodemer, C ;
Ali, M ;
Hamel-Teillac, D ;
Wilkinson, J ;
Bonafé, JL ;
Paradisi, M ;
Kelsell, DP ;
Ansai, S ;
Mitsuhashi, Y ;
Larrègue, M ;
Leigh, IM ;
Harper, JI ;
Taïeb, A ;
de Prost, Y ;
Cardon, LR ;
Hovnanian, A .
AMERICAN JOURNAL OF HUMAN GENETICS, 2000, 66 (03) :914-921
[5]   Mutations in SPINK5, encoding a serine protease inhibitor, cause Netherton syndrome [J].
Chavanas, S ;
Bodemer, C ;
Rochat, A ;
Hamel-Teillac, D ;
Ali, M ;
Irvine, AD ;
Bonafé, JL ;
Wilkinson, J ;
Taïeb, A ;
Barrandon, Y ;
Harper, JI ;
de Prost, Y ;
Hovnanian, A .
NATURE GENETICS, 2000, 25 (02) :141-142
[6]  
CHEN JY, 1996, DERMATOL SINICA, V14, P251
[7]   RNA surveillance - unforeseen consequences for gene expression, inherited genetic disorders and cancer [J].
Culbertson, MR .
TRENDS IN GENETICS, 1999, 15 (02) :74-80
[8]   A CLINICAL AND IMMUNOLOGICAL STUDY OF NETHERTONS SYNDROME [J].
JUDGE, MR ;
MORGAN, G ;
HARPER, JI .
BRITISH JOURNAL OF DERMATOLOGY, 1994, 131 (05) :615-621
[9]   Elevated stratum corneum hydrolytic activity in Netherton syndrome suggests an inhibitory regulation of desquamation by SPINK5-derived peptides [J].
Komatsu, N ;
Takata, M ;
Otsuki, N ;
Ohka, R ;
Amano, O ;
Takehara, K ;
Saijoh, K .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2002, 118 (03) :436-443
[10]   Inhibition of NF-κB activation and augmentation of IκBβ by secretory leukocyte protease inhibitor during lung inflammation [J].
Lentsch, AB ;
Jordan, JA ;
Czermak, BJ ;
Diehl, KM ;
Younkin, EM ;
Sarma, V ;
Ward, PA .
AMERICAN JOURNAL OF PATHOLOGY, 1999, 154 (01) :239-247